BIG2 Activators

BIG2 activators encompass a range of chemical entities that enhance the guanine nucleotide exchange factor (GEF) activity of BIG2 on ADP-ribosylation factors (ARFs). Non-hydrolyzable GTP analogs like GTPγS bind to ARF proteins, maintaining them in an active state, which facilitates the GEF function of BIG2. Similarly, the stabilization of F-actin by Jasplakinolide indirectly promotes the recruitment of ARF proteins to the membranes, augmenting BIG2 activity by increasing substrate availability. Modulation of the cellular environment is another strategy employed by BIG2 activators; Forskolin, for instance, elevates cAMP levels, which can lead to an enhanced BIG2-mediated ARF protein activation. Moreover, the membrane phospholipid PIP2 serves to recruit both ARF proteins and BIG2 to the plasma membrane, optimizing GEF activity through spatial proximity. Metal ions like Zn2+ can elicit allosteric changes in BIG2, improving its interaction with ARF proteins, while Ca2+/calmodulin complexes may also augment BIG2's GEF function by fostering interactions with ARF proteins and stabilizing ARF in its GTP-bound form.

The complexity of BIG2 regulation is further exemplified by activators that influence the protein indirectly through upstream signaling pathways or cytoskeletal dynamics. Clostridium difficile Toxin B, for example, modifies the actin cytoskeleton by inactivating Rho proteins, which can lead to enhanced BIG2 activity. The signaling molecule nitric oxide can potentiate BIG2's GEF activity through S-nitrosylation of cysteine residues on BIG2 or ARF proteins, thus improving their interaction. Lysophosphatidic acid activates G protein-coupled receptors that lead to Rho activation and actin cytoskeletal rearrangements, indirectly facilitating BIG2 activity. The use of another GTP analog, Guanosine 5'-O-(3-Thio)triphosphate, similarly promotes the GEF function of BIG2 by mimicking the GTP-bound ARF state. Epidermal Growth Factor (EGF), by activating receptor tyrosine kinases, initiates signaling cascades that can culminate in ARF activation, thereby enhancing BIG2's role in facilitating GTP-loading of ARF proteins. Collectively, these diverse molecules constitute the BIG2 activators, each contributing to the enhancement of BIG2's GEF activity through various direct and indirect mechanisms.